How does your management change for patients with bone marrow failure due to a metastatic solid tumor to the marrow?

This is not an uncommon scenario in small cell lung cancer. Unfortunately, there are not much data to guide management, as most clinical trials exclude patients with abnormal counts. In this setting, I take the approach that if all other organ functions are acceptable, the bone marrow is unlikely to...